【レポートの概要（一部）】
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, By Indication
5.1 Introduction
5.2 Breast Cancer
5.3 Colorectal Cancer
5.4 Lung Cancer
5.5 Others Indications
6 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, By Blocking Drug
6.1 Introduction
6.2 Monoclonal Antibodies
6.2.1 Cetuximab
6.2.2 Necitumumab
6.3 Tyrosine Kinase Inhibitors (TKI)
6.3.1 Erlotinib
6.3.2 Gefitinib
7 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Amgen Inc
9.2 Bristol-Myers Squibb
9.3 Erbitux
9.4 F. Hoffmann-La Roche Ltd
9.5 Genentech, Inc
9.6 OSI Pharmaceuticals Inc
9.7 Tarceva
9.8 Vectibix
List of Tables
Table 1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 6 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 7 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 8 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 9 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 10 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 11 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 12 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 13 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 14 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 15 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 16 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 17 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 18 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 19 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 20 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 21 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 22 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 23 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 24 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 25 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 26 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 27 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 28 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 29 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 30 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 31 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 32 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 33 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 34 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 35 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 36 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 37 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 38 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 39 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 40 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 41 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 42 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 43 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 44 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 45 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 46 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 47 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 48 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 49 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 50 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 51 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 52 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 53 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 54 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 55 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 56 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 57 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 58 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 59 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 60 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 61 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 62 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 63 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 64 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 65 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 66 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 67 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 68 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 69 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 70 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 71 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 72 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 73 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 74 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 75 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 76 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 77 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 78 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
【レポート販売概要】
■ タイトル：上皮増殖因子受容体（EGFR）阻害薬の世界市場展望2017-2026■ 英文：Epidermal Growth Factor Receptor (EGFR) Inhibitors - Global Market Outlook (2017-2026)
■ 発行日：2019年6月
■ 調査会社：Stratistics MRC
■ 商品コード：SMRC90773
■ 調査対象地域：グローバル
- セキュリティアドバイザリーサービスの世界市場予測（～2024年）The security advisory services market is expected to grow at a CAGR of 19.3% during the forecast period due to the push from regulatory bodies across the globe and increase in adoption of hybrid network environment The global security advisory services market size is expected to grow from USD 7.8 billion in 2019 to USD 18.8 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 19.3% during t …
- 世界における小型自動車用OE(メーカー純正部品)基礎ブレーキ装置市場動向と予測（～2029）This latest just-auto report edition offers a global review of the OE foundation braking sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE foundation braking market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategi …
- Pharyngitis：グローバル臨床試験レビューH2, 2013Pharyngitis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Pharyngitis Global Clinical Trials Review, H2, 2013" provides data on the Pharyngitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pharyngitis. It includes an overview of the trial numbers and their recruitment status as per the site of …
- バケーションレンタルの世界市場2015-2019Technavio’s market research analyst believes that the global vacation rental market will reach $169.7 billion by 2019. The key regions where global vacation rental adoption is highest are Europe and North America, wherein the awareness of the concept of a vacation rental is widespread. The entry of new technologically oriented start-ups and higher interest in vacation rentals among travelers is on …
- Sexually-Transmitted Diseases in Italy 2014: Market Outlook and Emerging OpportunitiesAbout This ReportThis new 280-pages report from Venture Planning Group presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.In addition to market sh …
- 世界の無人航空機（UAV）市場動向2013-2023：地域別分析"The Global UAV Market 2013-2023 - Country Analysis: Market Profile" provides details of the key markets in each region, offering an analysis of the top segments of UAV, expected to be in demand. It also investigates the top three expected UAV programs, in terms of demand in the key markets in each region.
- リンパ芽球性リンパ腫：世界の臨床試験レビュー（2014年上半期）Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the Lymphoblastic Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lymphoblastic Lymphoma. It includes an overview of the trial numbers and …
- 世界のセイボリー及びデリカテッセン食品市場：ニュース、イベント動向（2014年3月）Synopsis The report provides a review of the latest news and key events in the global savory & deli foods market during March 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global savory & deli foods market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest ev …
- 振動子の世界市場2017-2021：水晶振動子、MEMS振動子About ResonatorsResonators are a key element responsible for the performance of radio-frequency (RF)/microwave components including filters. Different types of resonators include dielectric, coaxial, ceramic, crystal, and surface acoustic wave (SAW). The characteristics of each resonator vary differently. Technavio’s analysts forecast the global resonators market to grow at a CAGR of 17.19% during …
- バイオポリマーの世界市場2017-2021About Biopolymers Polymers, which are petrochemical derivatives, account for about 80% of the total polymeric materials globally produced. Polymer production has been a cause of concern to nations worldwide. The dependency on the petrochemical industry had been irreplaceable until the discovery of biopolymers two decades ago. The emergence of biopolymers is seen as a step toward sustainable develo …
- 繊維強化ポリマ（FRP）パネル＆シートの世界市場予測（～2021）The market size of continuous laminated FRP panels & sheets is projected to reach USD 1,084.7 Million by 2021, at a CAGR of 6.53% between 2016 and 2021. The growing manufacturing industries and continuous new product launches, partnerships, expansions, and mergers & acquisitions undertaken by various companies are the key growing factors of the global FRP panels & sheets market. The recreational v …
- 世界の生命工学ソフトウェア市場動向（2012-2016）TechNavio's analysts forecast the Global Life Sciences Software market to grow at a CAGR of 9.48 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased need for storing and effectively using patient information. The Global Life Sciences Software market has also been witnessing the emergence of SaaS-based solutions. However, the high cost of im …
- インドの教育用ハードウェア市場2016-2020About the Education Hardware Market Educational institutions deploy hardware to fulfill the purpose of learning and education. In the past few years, the use of PCs has increased because of the evolution of the learning and teaching methodology. Educational institutions are developing innovative teaching methods and relevant IT tools for students and staff for improved efficiencies and learning pr …
- アルミダイカスト機械の世界市場2018-2022About Aluminum Die Casting Machinery Aluminum die casting machinery is used to produce aluminum cast parts to be used in the production process in various end-user sectors. Aluminum die casting machinery by product type is segmented into high-pressure die casting (HPDC), low-pressure die casting (LPDC), and others. Technavio’s analysts forecast the global aluminum die casting machinery market to g …
- 世界の神経診断市場：製品別（診断および画像システム（MRI、超音波）、臨床検査（PCR、NGS）、試薬および消耗品）、疾患病理学別（てんかん、脳卒中）、エンドユーザー別、地域別“The global neurodiagnostics market is projected to grow at a CAGR of 7.3% during the forecast period.” The global neurodiagnostics market is expected to reach USD 8.4 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 7.3%. The demand for neurodiagnostic products is expected to grow due to the increasing prevalence of neurological disorders & diseases. The neurodiagnostics market is segme …
